abstract |
Use of a glycerophosphoinositol derivative as a modulator of cytosolic phospholipase. An M salt of L-α-glycero-phospho-D-myo-inositol as an active ingredient together with a pharmaceutically acceptable excipient, wherein M is a pharmacologically acceptable inorganic element Or a pharmacologically acceptable organic base having the value n + (where n is 1, 2 or 3). } A superficial topical pharmaceutical composition for the treatment of dermatitis, UV-induced cutaneous erythema, or mucosal inflammatory stimulus. [Selection figure] None |